Journals / The Anatolian Journal of Cardiology / 2018 / Cilt: 19 - Sayı: 1

Impact of gender and age on the association of the BUD13-ZNF259 rs964184 polymorphism with coronary heart disease

Pages
42–49
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our results indicate that both gender and age have great impacts on the association of the rs964184 polymorphism with CHD among Chinese. (Anatol J Cardiol 2018; 19: 42-9)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Coronary heart disease (CHD) is the most common cause of death worldwide.
📊
Key Findings & Data:This study aimed to validate the association of the rs964184 polymorphism with the CHD risk and included 874 CHD patients and 776 controls.
💡
Conclusion & Impact:Conclusion: Our results indicate that both gender and age have great impacts on the association of the rs964184 polymorphism with CHD among Chinese. (Anatol J Cardiol 2018; 19: 42-9)
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Coronary heart disease (CHD) is the most common cause of death worldwide. This study aimed to validate the association of the rs964184 polymorphism with the CHD risk and included 874 CHD patients and 776 controls. Methods: rs964184 polymorphism genotyping was performed using Tm-shift polymerase chain reaction. Results: A strong association of the rs964184 polymorphism with CHD was found (genotype: X2 =14.365, p=0.001; allele: X2 =14.191, p=1.6710–4 ; power=0.965). Gender analysis revealed a significant association only in males (genotype: X2 =12.387, p=0.002; allele: X2 =12.404, p=4.3210–4 ; OR=1.467, 95% CI=1.185–1.817, power=0.945). Age and gender analyses revealed significant associations of the rs964184 polymorphism with CHD in males between the ages of 55 and 65 years (genotype: X2 =10.070, p=0.007; allele: X2 =10.077, p=0.002; OR=1.706, 95% CI=1.224–2.377, power=0.996) and in females older than 65 years (genotype: X2 =9.462, p=0.009; allele: X2 =9.560, p=0.002; OR=2.112, 95% CI=1.308–3.412, power=0.994). Further subgroup analysis suggested that rs964184 genotypes were significantly associated with TG levels in the patients (r=0.191, adjusted p=1.05 10–5 ) and controls (r=0.101, adjusted p=0.026). Conclusion: Our results indicate that both gender and age have great impacts on the association of the rs964184 polymorphism with CHD among Chinese. (Anatol J Cardiol 2018; 19: 42-9)

🔖

Cite This Article

XU, X., Lİ, Y., HUANG, Y., YE, H., HAN, L., Jİ, H., CHEN, X., WU, N., XU, L., DAİ, D., DUAN, S., CHEN, X. (2018). Impact of gender and age on the association of the BUD13-ZNF259 rs964184 polymorphism with coronary heart disease. The Anatolian Journal of Cardiology, Cilt: 19 - Sayı: 1, 42–49. https://ajindex.com/articles/365799

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010; 464: 1357-61.
  2. Bijli KM, Fazal F, Minhajuddin M, Rahman A. Activation of Syk by protein kinase C-delta regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via tyrosine phosphorylation of RelA/p65. J Biol Chem 2008; 283: 14674-84.
  3. Hilgendorf I, Eisele S, Remer I, Schmitz J, Zeschky K, Colberg C, et al. The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 2011; 31: 1991-9.
  4. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 2009; 27: 165-97.
  5. Joakimsen O, Bonaa KH, Stensland-Bugge E, Jacobsen BK. Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis: The Tromso Study. J Clin Epidemiol 2000; 53: 525-30.
  6. Leibar Tamayo A, Astobieta Odriozola A, Garcia-Cruz E, Cordero Fort A, Romero Otero J. Testosterone and coronary artery disease. Arch Esp Urol 2013; 66: 689-95.
  7. Zhao Y, Tian F, Hu SY, Wang J, Zhang T, Chen YD, et al. [Characteristics of traditional risk factors and coronary lesions on coronary heart disease among different sex populations]. Zhonghua Liu Xing Bing Xue Za Zhi 2012; 33: 423-7.
  8. Ginter E, Simko V. Women live longer than men. Bratisl Lek Listy 2013; 114: 45-9.
  9. Rinkuniene E, Petrulioniene Z, Laucevicius A, Ringailaite E, Laucyte A. [Prevalence of conventional risk factors in patients with coronary heart disease]. Medicina (Kaunas) 2009; 45: 140-6.
  10. Hughes MF, Saarela O, Stritzke J, Kee F, Silander K, Klopp N, et al. Genetic markers enhance coronary risk prediction in men: the MORGAM prospective cohorts. PLoS One 2012; 7: e40922. Bressler J, Folsom AR, Couper DJ, Volcik KA, Boerwinkle E. Genetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study. Am J Epidemiol 2010; 171: 14-23. Christiansen MK. Early-onset Coronary Artery Disease Clinical and Hereditary Aspects. Dan Med J 2017; 64. Rubin JB, Borden WB. Coronary heart disease in young adults. Curr Atheroscler Rep 2012; 14: 140-9.
  11. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics--2011 update: a report from the America